Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
NCT00668122
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
212
Enrollment
INDUSTRY
Sponsor class
Conditions
Urinary Tract Infection
Interventions
DRUG:
Cipro XR (Ciprofloxacin, BAYQ3939)
DRUG:
Cipro IR (Ciprofloxacin, BAYQ3939)
Sponsor
Bayer